Literature DB >> 14998473

[Patient preference in the choice of dry powder inhalers].

J Giner1, M Torrejón, A Ramos, P Casan, C Granel, V Plaza, J Belda, J Sanchis.   

Abstract

OBJECTIVE: To investigate a group of patients' preferences among 3 dry powder inhalers--Accuhaler, Easyhaler, and Turbuhaler--and to analyze the features that were most important for motivating choices. MATERIAL AND
METHOD: The study enrolled 30 patients with stable asthma with a mean (SD) age of 40 (13) and who habitually used inhaled corticosteroids. The patients were shown in detail how to use each of the devices and were randomized to begin using them in different orders. After using each inhaler for a week, the patients assessed 9 different features on a scale of 0 to 10 with an independent observer. The patients were asked to put the inhalers in order of preference, and finally to demonstrate they could use them correctly.
RESULTS: All patients correctly performed the inhalation maneuver at the beginning and the end of the study. The mean final scores out of 90 of the 9 features evaluated were 75 (13) for the Easyhaler, 67 (12) for the Accuhaler, and 65 (14) for the Turbuhaler. Differences were statistically significant between the first and the second device (P=0.02) and the first and the third (P=.001) but not between the Accuhaler and the Turbuhaler (P=.376). Mean rating scores were 8.6 (1.4) for the Easyhaler, 7.3 (1.9) for the Turbuhaler, and 7.1 (1.6) for the Accuhaler. The Easyhaler was the first choice for 53% of patients, the Turbuhaler for 27%, and the Accuhaler for 20%.
CONCLUSIONS: The Easyhaler was rated the highest by the patients in the study. The scores were a long way from the maximum score, so research into developing an ideal inhaler must continue.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998473     DOI: 10.1016/s1579-2129(06)70074-x

Source DB:  PubMed          Journal:  Arch Bronconeumol        ISSN: 0300-2896            Impact factor:   4.872


  11 in total

1.  In Vitro Flow Rate Dependency of Delivered Dose and Fine Particle Dose of Salmeterol/Fluticasone Propionate Easyhaler and Seretide Diskus with Patient Flow Rates Collected in a Randomized Controlled Trial.

Authors:  Rain Jõgi; Satu Lähelmä; Mikko Vahteristo; Anita Happonen; Jussi Haikarainen
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2018-10-09       Impact factor: 2.849

2.  Ease-of-use, preference, confidence, and satisfaction with Revolizer(®), a novel dry powder inhaler, in an Indian population.

Authors:  Sujeet K Rajan; Jaideep A Gogtay
Journal:  Lung India       Date:  2014-10

3.  Role of a Community Pharmacy Service in Care of Bronchial Asthma Patients in Lithuania.

Authors:  Arturas Nastaravičius; Kristina Ramanauskienė
Journal:  Can Respir J       Date:  2018-08-19       Impact factor: 2.409

Review 4.  The Diskus: a review of its position among dry powder inhaler devices.

Authors:  H Chrystyn
Journal:  Int J Clin Pract       Date:  2007-06       Impact factor: 2.503

5.  Inhaler competence and patient satisfaction with Easyhaler®: results of two real-life multicentre studies in asthma and COPD.

Authors:  Gabriella Gálffy; Györgyi Mezei; Gyula Németh; Lilla Tamási; Veronika Müller; Olof Selroos; Marta Orosz
Journal:  Drugs R D       Date:  2013-09

6.  Switching patients from other inhaled corticosteroid devices to the Easyhaler(®): historical, matched-cohort study of real-life asthma patients.

Authors:  David Price; Vicky Thomas; Julie von Ziegenweidt; Shuna Gould; Catherine Hutton; Christine King
Journal:  J Asthma Allergy       Date:  2014-04-10

7.  Characteristics of reversible and nonreversible COPD and asthma and COPD overlap syndrome patients: an analysis of salbutamol Easyhaler data.

Authors:  Veronika Müller; Gabriella Gálffy; Márta Orosz; Zsuzsanna Kováts; Balázs Odler; Olof Selroos; Lilla Tamási
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-01-12

8.  Inhaler Technique in Asthma: How Does It Relate to Patients' Preferences and Attitudes Toward Their Inhalers?

Authors:  Lia Jahedi; Sue R Downie; Bandana Saini; Hak-Kim Chan; Sinthia Bosnic-Anticevich
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2016-09-27       Impact factor: 2.849

9.  Prevalence of modifiable factors limiting treatment efficacy of poorly controlled asthma patients: EFIMERA observational study.

Authors:  Paula Ribó; Jesús Molina; Myriam Calle; Luis Maiz; Carlos Campo; Paula Rytilä; Vicente Plaza; Antonio Valero
Journal:  NPJ Prim Care Respir Med       Date:  2020-07-31       Impact factor: 2.871

10.  Preference for Easyhaler® Over Previous Dry Powder Inhalers in Asthma Patients: Results of the DPI PREFER Observational Study.

Authors:  Francisco Javier Alvarez-Gutiérrez; Ana Gómez-Bastero Fernández; Juan Francisco Medina Gallardo; Carlos Campo Sien; Paula Rytilä; Julio Delgado Romero
Journal:  Patient Prefer Adherence       Date:  2021-02-16       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.